Compare RUSHA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUSHA | APGE |
|---|---|---|
| Founded | 1965 | 2022 |
| Country | United States | United States |
| Employees | 7355 | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.7B |
| IPO Year | N/A | 2023 |
| Metric | RUSHA | APGE |
|---|---|---|
| Price | $76.30 | $86.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $71.33 | ★ $109.67 |
| AVG Volume (30 Days) | 339.7K | ★ 616.5K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.44 | N/A |
| P/E Ratio | $21.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $45.67 | $34.34 |
| 52 Week High | $76.45 | $95.32 |
| Indicator | RUSHA | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 72.34 | 55.37 |
| Support Level | $69.37 | $73.06 |
| Resistance Level | N/A | $95.32 |
| Average True Range (ATR) | 1.94 | 3.61 |
| MACD | 0.56 | -0.67 |
| Stochastic Oscillator | 95.02 | 36.11 |
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.